about
GB Virus C (GBV-C) Infection in Hepatitis C Virus (HCV) Seropositive Women with or at Risk for HIV InfectionShifting the paradigm: using HIV surveillance data as a foundation for improving HIV care and preventing HIV infection.A Comparison of Methods for Analyzing Viral Load Data in Studies of HIV Patients.Human leukocyte antigen class I supertypes and HIV-1 control in African Americans.Structural factors and best practices in implementing a linkage to HIV care program using the ARTAS model.Delivery of an HIV prevention counseling program in an infectious diseases clinic: implementation process and lessons learned.HIV mono-infection is associated with FIB-4 - A noninvasive index of liver fibrosis - in womenEnhanced personal contact with HIV patients improves retention in primary care: a randomized trial in 6 US HIV clinics.Mortality rates and causes of death in a cohort of HIV-infected and uninfected women, 1993-1999.Measuring retention in HIV care: the elusive gold standard.A low-effort, clinic-wide intervention improves attendance for HIV primary care.Estimating the cost of increasing retention in care for HIV-infected patients: results of the CDC/HRSA retention in care trialThe association of clinical follow-up intervals in HIV-infected persons with viral suppression on subsequent viral suppression.Time above 1500 copies: a viral load measure for assessing transmission risk of HIV-positive patients in care.The influence of human leukocyte antigen class I alleles and their population frequencies on human immunodeficiency virus type 1 control among African AmericansPsychosocial characteristics and sexual behaviors of people in care for HIV infection: an examination of men who have sex with men, heterosexual men and womenClinic-wide intervention lowers financial risk and improves revenue to HIV clinics through fewer missed primary care visits.Evaluating patterns in retention, continuation, gaps, and re-engagement in HIV care in a Medicaid-insured population, 2006-2012, United States.Reengagement in Care After a Gap in HIV Care Among a Population of Privately Insured Persons with HIV in the United States.Continuity of medical care and risk of incarceration in HIV-positive and high-risk HIV-negative women.Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women.Rates and risk factors for condition-specific hospitalizations in HIV-infected and uninfected women.Test-retest reliability of a complex human immunodeficiency virus research questionnaire administered by an Audio Computer-assisted Self-interviewing system.Single Viral Load Measurements Overestimate Stable Viral Suppression Among HIV Patients in Care: Clinical and Public Health Implications.Assessing efficacy of a retention-in-care intervention among HIV patients with depression, anxiety, heavy alcohol consumption and illicit drug use.Faster entry into HIV care among HIV-infected drug users who had been in drug-use treatment programs.Linking recently diagnosed HIV-positive persons to medical care: perspectives of referring providers.The spectrum of engagement in HIV care: do more than 19% of HIV-infected persons in the US have undetectable viral load?HIV transmission risk behaviors among HIV-infected persons who are successfully linked to care.HIV testing factors associated with delayed entry into HIV medical care among HIV-infected persons from eighteen states, United States, 2000-2004.Implementation and evaluation of a clinic-based behavioral intervention: positive steps for patients with HIV.Entry and retention in medical care among HIV-diagnosed persons: a meta-analysis.Frequency of discussing HIV prevention and care topics with patients with HIV: influence of physician gender, race/ethnicity, and practice characteristics.Improved prevention counseling by HIV care providers in a multisite, clinic-based intervention: Positive STEPs.Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care.System and patient barriers to appropriate HIV care for disadvantaged populations: the HIV medical care provider perspective.Use of highly active antiretroviral therapy in HIV-infected women: impact of HIV specialist care.Do Persons Living with HIV Continue to Fill Prescriptions for Antiretroviral Drugs during a Gap in Care? Analysis of a Large Commercial Claims Database.Psychological and behavioral correlates of entering care for HIV infection: the Antiretroviral Treatment Access Study (ARTAS).Demographic, psychological, and behavioral modifiers of the Antiretroviral Treatment Access Study (ARTAS) intervention.
P50
Q28542648-C0DA91A0-4A45-466D-B986-2964C53F9916Q30666487-D5D35C81-73A9-4A88-A94A-BEED540CAFF4Q30975343-8147BFC8-7F44-4564-805A-95B8BD4CC10CQ33648970-E5CE11AC-3669-4ED0-B3E2-C96A9BC1FBF0Q33667631-44B68D6C-CC57-4E19-BBAC-BE8A50142AC9Q34035305-A1231D60-CC07-4118-A59A-2BE4C5761E82Q35019825-255277C4-A001-41A1-93D5-00295227EB64Q35197301-09DAB3AF-631E-4D8E-BBDB-14E4A40EDEEBQ35622250-40E26828-8C6F-46ED-B1E1-79847F921E7DQ36428000-8991A43A-EB00-421E-BE6D-BB77EB10AACFQ36854029-02A18EC2-D8C4-43D7-A0EE-FEB2FB829CE1Q36950796-763B60BE-C6FC-4462-99D2-3CA86860AD90Q37086072-B768C0EA-B56B-49E1-ABFF-42D14D187B25Q37135519-BA7EED1F-D3FD-4D21-A16B-4B5C80256645Q37186736-43521A15-C955-49D6-86FC-CCC64B205E28Q37196080-0ED1C154-9226-4BD6-9F13-A1ACDF858A6AQ37397560-26916EAD-922E-4B5A-8D16-D430559509A0Q38672438-3663A60B-AEF1-44D3-BECB-2EEFE21CFB98Q39010074-8DC8F02F-E173-4438-8F49-141D0B1F0835Q39641420-DB9A9EF8-3BE5-432B-BF01-F54303E06E93Q39641509-45CFE835-A7E4-4C15-B84B-D32D837C39DBQ39668656-B5A84A17-5E3C-4935-B306-CCB2301F234DQ40577817-14CFB5C8-E733-49D7-B7A2-7034E1BDA79DQ40703216-125C00B9-DFB0-4B75-A515-BCFF7274B602Q40835306-10EDD3CB-EA21-420A-B9B1-093AB74B4627Q42103529-CC64BDFA-045D-4295-AEA2-48A6F3B69411Q42685774-9DBD7D06-986F-4873-8D62-F4DC7844DC6FQ43537641-9BFA65F9-AA70-41BD-A35C-4960908DA445Q43599320-9FFF8C66-FC55-4077-B204-6D8341161867Q43805117-6BC4BF05-B044-4CD1-BB61-7D38C47D48AEQ43922376-D4114C32-215C-45E5-B261-ECA42C15B7CEQ44386629-C057FE4C-C6C1-4F83-9D6C-2B9E9E94FB5DQ44479172-ECFD6C04-6F68-4E0D-A5F0-CBB8FC45A82EQ44975718-20239283-9B83-4DDF-9F7F-E5D3AB94ADF4Q45305778-7E606DC2-C3CD-48E0-8E10-94D42894DE2BQ46573198-E3B684DF-BA70-4687-9B5C-F24F855AA1C8Q50118207-B493F63E-892C-4B4F-AF8B-4ED1D866ED1FQ50129820-B826977B-B408-47BF-ADF3-2F3D660E3F52Q50153468-EDC3373D-2E79-4205-88D6-18FEEDB375B0Q50183547-5C7DE0B3-5B1D-4828-93B1-CFAE4C253B4D
P50
name
Lytt I Gardner
@en
type
label
Lytt I Gardner
@en
prefLabel
Lytt I Gardner
@en